Login

Tim Fitzpatrick, CEO and Co-Founder of IKONA Health, discusses their innovative kidney education platform designed for improved learning outcomes. 00:10:00

Share On Facebook Share On Twitter

David Cho is CEO of IKONA Partners

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Goldseek is poised to deliver shareholder value through rigorous exploration and development on these properties|Jon Deluce, CPA, CA,Abitibi Metals (IE)
00:10:00
portfolio includes 51 companies valued at over $1 billion|Christine Tsai,CEO and Founding Partner,500 Global
00:10:00
A disciplined approach applying a consistent strategy|MARC VINAGRAY, Senior Associate,Pomona Capital
00:00:00
Innovation to Impact: Knee Outcomes for Medical Professionals-Daniel B. F. Saris, M.D., Ph.D. Orthopedic Surgeon, Mayo Clinic
00:10:00
Airspan discusses its strategy to lead the Private Network market | Eric D. Stonestrom, CEO, Airspan Networks Holdings IncMIMO:ASQ
00:10:00
BBVA Asset Management Market Focus – March 2022: Embracing Diversification with Private Markets
00:10:00
Takes a low-volume high conviction approach|Jason Shuman,General Partner,Primary Venture Partners
00:10:00
The Regulatory Revolution Against Mergers: Insights from Robert Atkinson of ITIF’s Schumpeter Project on Competition Policy | Robert Atkinson - President, Information Technology and Innovation Foundation (ITIF)
00:10:00
A provider of new and effective solutions within wound care cancer therapies and other immune related disease areas|Svein WF Lien, CEO,Biotec Pharmacon
00:10:00
"Phoenix Firm Collaborates with EP Wealth Advisors" | DEREK HOLMAN - Co-founder and Managing Director of EP Wealth Advisors
00:10:00
Mastering Market Timing: Real Estate Insights with Fred Gortner | Paladin Realty
00:10:00
Venture capital firm on a mission to diversify the face of wealth|Diana Murakhovskaya,Co-Founder and General Partner,The Artemis Fund

© 2017 - Neuhu+